207 related articles for article (PubMed ID: 36639521)
1. The impact of high on-treatment platelet reactivity and fibrinogen levels on ischemic events in patients with ST elevation myocardial infarction: a prospective observational study.
Yao Y; Li X; Wang Z; Xu S; Lv Q
Int J Clin Pharm; 2023 Apr; 45(2):461-472. PubMed ID: 36639521
[TBL] [Abstract][Full Text] [Related]
2. Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor.
Nardin M; Verdoia M; Sartori C; Pergolini P; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G;
J Cardiovasc Pharmacol; 2015 Oct; 66(4):364-70. PubMed ID: 26065844
[TBL] [Abstract][Full Text] [Related]
3. Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study.
Nardin M; Verdoia M; Pergolini P; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G;
Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):567-574. PubMed ID: 27134063
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid Hormone Levels and High-Residual Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy With Acetylsalicylic Acid and Clopidogrel or Ticagrelor.
Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G;
Cardiovasc Ther; 2016 Aug; 34(4):209-15. PubMed ID: 27086085
[TBL] [Abstract][Full Text] [Related]
5. Uric acid and high-residual platelet reactivity in patients treated with clopidogrel or ticagrelor.
Barbieri L; Verdoia M; Pergolini P; Nardin M; Rolla R; Marino P; Bellomo G; Suryapranata H; De Luca G;
Nutr Metab Cardiovasc Dis; 2016 Apr; 26(4):352-8. PubMed ID: 26857781
[TBL] [Abstract][Full Text] [Related]
6. High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI.
Parodi G; Marcucci R; Valenti R; Gori AM; Migliorini A; Giusti B; Buonamici P; Gensini GF; Abbate R; Antoniucci D
JAMA; 2011 Sep; 306(11):1215-23. PubMed ID: 21934054
[TBL] [Abstract][Full Text] [Related]
7. Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G
Expert Opin Pharmacother; 2015; 16(12):1739-47. PubMed ID: 26067422
[TBL] [Abstract][Full Text] [Related]
8. Low hemoglobin predicts high-platelet reactivity and major cardiovascular ischemic events at long-term follow-up among ACS patients receiving dual antiplatelet therapy with ticagrelor.
Verdoia M; Rolla R; Pergolini P; Gioscia R; Nardin M; Negro F; Viglione F; Suryapranata H; Kedhi E; De Luca G;
Catheter Cardiovasc Interv; 2021 Dec; 98(7):1309-1316. PubMed ID: 33527669
[TBL] [Abstract][Full Text] [Related]
9. Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
Verdoia M; Pergolini P; Rolla R; Nardin M; Schaffer A; Barbieri L; Marino P; Bellomo G; Suryapranata H; De Luca G
J Thromb Haemost; 2016 Jan; 14(1):57-64. PubMed ID: 26512550
[TBL] [Abstract][Full Text] [Related]
10. Effect of Clopidogrel vs Ticagrelor on Platelet Aggregation and Inflammation Markers After Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.
Jiang Z; Zhang R; Sun M; Liu Q; Wang S; Wang W; Zhao Q; Zhang H; Wang Y; Hou J; Yu B
Can J Cardiol; 2018 Dec; 34(12):1606-1612. PubMed ID: 30527148
[TBL] [Abstract][Full Text] [Related]
11. Impact of renal failure and high-platelet reactivity on major cardiovascular ischemic events among patients with acute coronary syndrome receiving dual antiplatelet therapy with ticagrelor.
Verdoia M; Nardin M; Gioscia R; Suryapranata H; Kedhi E; Rognoni A; DE Luca G;
Minerva Cardiol Angiol; 2023 Jun; 71(3):257-265. PubMed ID: 36222601
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum C1q is an independent predictor of high residual platelet reactivity in CAD patients receiving clopidogrel therapy.
Zhao Z; Ma M; Huang X; Sun T; Han K; Yang S; Zhou Y
Front Immunol; 2022; 13():969984. PubMed ID: 36248871
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D levels and platelet reactivity in diabetic patients receiving dual antiplatelet therapy.
Verdoia M; Pergolini P; Nardin M; Rolla R; Negro F; Kedhi E; Suryapranata H; Marcolongo M; Carriero A; De Luca G;
Vascul Pharmacol; 2019 Sep; 120():106564. PubMed ID: 31176855
[TBL] [Abstract][Full Text] [Related]
14. Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study.
Stuckey TD; Kirtane AJ; Brodie BR; Witzenbichler B; Litherland C; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Gurbel PA; Mehran R; Généreux P; Ben-Yehuda O; Simonton CA; Stone GW;
JACC Cardiovasc Interv; 2017 Aug; 10(16):1607-1617. PubMed ID: 28780034
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation.
Verdoia M; Sartori C; Pergolini P; Nardin M; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G;
Vascul Pharmacol; 2016 Feb; 77():48-53. PubMed ID: 25956733
[TBL] [Abstract][Full Text] [Related]
16. Short-term efficacy of ticagrelor in acute ST-segment elevation myocardial infarction patients undergoing an emergency percutaneous coronary intervention.
Cao B; Qu F; Liu X; Gao C; Fu Q; Jiang C; Wei P; Ma Q
Aging (Albany NY); 2019 Oct; 11(20):8925-8936. PubMed ID: 31665124
[TBL] [Abstract][Full Text] [Related]
17. [The variation of serum uric acid levels among patients with myocardial infarction treated with ticagrelor and the association between serum uric acid and platelet reactivity].
Song L; Xu DY; Zhou P; Liu C; Sheng ZX; Li JN; Zhou JY; Chen RZ; Chen Y; Zhao HJ; Yan HB
Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Feb; 49(2):170-175. PubMed ID: 33611904
[No Abstract] [Full Text] [Related]
18. Impact of atorvastatin or rosuvastatin co-administration on platelet reactivity in patients treated with dual antiplatelet therapy.
Verdoia M; Nardin M; Sartori C; Pergolini P; Rolla R; Barbieri L; Marino P; Bellomo G; Suryapranata H; De Luca G;
Atherosclerosis; 2015 Dec; 243(2):389-94. PubMed ID: 26520891
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Ticagrelor in Comparison to Clopidogrel in Elderly Patients With ST-Segment-Elevation Myocardial Infarctions.
Schmucker J; Fach A; Mata Marin LA; Retzlaff T; Osteresch R; Kollhorst B; Hambrecht R; Pohlabeln H; Wienbergen H
J Am Heart Assoc; 2019 Sep; 8(18):e012530. PubMed ID: 31538856
[TBL] [Abstract][Full Text] [Related]
20. Platelet function testing guided antiplatelet therapy reduces cardiovascular events in Chinese patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: The PATROL study.
You J; Li H; Guo W; Li J; Gao L; Wang Y; Geng L; Wang X; Wan Q; Zhang Q
Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():598-605. PubMed ID: 31957972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]